REGENCOR, INC.; INC.;SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE;REGENCOR
发明人:
RUIZ-LOZANO, PILAR,MERCOLA, MARK,WEI, KE
申请号：
CA2982179
公开号：
CA2982179A1
申请日:
2016.04.08
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
Provided herein, inter alia, are compositions and kits comprising epi cardial-derived paracrine factors (such as, hypoglycosylated folli statin-like 1 (FSTL1)) for treating and repairing damage to cardiac tissue caused by cardiovascular disease, myocardial infarction (MI), other ischemic events, or cardiac-growth deficiency, as well as methods for using the same.
